CBA Pharma, Inc.
|CBA Pharma, Inc. Patent applications|
|Patent application number||Title||Published|
|20150073151||SUPERCRITICAL FLUID EXTRACTION OF BIS-BENZYL ISOQUINOLINES - An improved process for obtaining at least one bis-benzyl isoquinoline alkaloid from botanical material involves contacting the botanical material with a supercritical fluid having as a major component one or more aliphatic hydrocarbon compounds, such as alkanes, alkenes, cyclic aliphatic hydrocarbons, or a combination of these compounds.||03-12-2015|
|20140275157||METHOD AND PRODUCTS FOR ENHANCING CELLULAR UPTAKE OF DRUG AND DIETARY SUPPLEMENTS - Enhancing the cellular uptake of a drug or dietary supplement by administering it concurrently with one or more members of the d-tetrandrine family.||09-18-2014|
|20140275140||METHOD AND PRODUCTS FOR ENHANCING DRUG AND DIETARY SUPPLEMENT BIOAVAILABILITY - Enhancing the bioavailability of a drug or dietary supplement by administering it concurrently with one or more members of the d-tetrandrine family.||09-18-2014|
|20140275138||METHOD AND PRODUCTS FOR TREATING DIABETES - Treating diabetes by administering one or more members of the d-tetrandrine family, either alone or with other Type 2 diabetes drugs or dietary supplements which mediate diabetes.||09-18-2014|
|20140275137||TETRANDRINE FAMILY PHARMACEUTICAL FORMULATIONS AND METHOD - Drug formulations, methods and their use in treatment of diseases using formulations of pure di-acid salts of tetrandrine family members, especially d-tetrandrine di-hydrochloride, combined with a pharmaceutical diluent or carrier.||09-18-2014|
|20140135354||TETRANDRINE PHARMACEUTICAL FORMULATIONS AND METHOD - Drug formulations, methods and their use in treatment of diseases using the free base formulations of tetrandrine family members, especially d-tetrandrine, combined with a pharmaceutical diluent or carrier.||05-15-2014|
|20140073591||MDR METHOD AND PRODUCTS FOR TREATING MRSA - Multidrug resistance reversers of the d-tetrandrine family are used in conjunction with penicillins and other principle drugs used to treat MRSA.||03-13-2014|
Patent applications by CBA Pharma, Inc.